Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Not Yet Recruiting

Early Intervention

NCT05326165

Conditions: Breast Cancer, Breast Cancer Lymphedema, Breast Cancer Treatment Related Lymphedema, +12 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Testing Mosunetuzumab Alone, With Zanubrutinib, or With Polatuzumab Vedotin for Treating Marginal Zone Lymphoma That Came Back or Didn't Get Better With Treatment

NCT07638722

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT07599423

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers

NCT07696169

Conditions: AIDS, AIDS-Related Malignancy, Acquired Immunodeficiency Syndrome, +61 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia

NCT07696481

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +17 more
Locations: Department of Hematology, Zhujiang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Real-World Study of Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

NCT07695896

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Not Yet Recruiting

Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma

NCT07691450

Conditions: Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +36 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Not Yet Recruiting

A Clinical Study on the Efficacy and Safety of Zeprumetostat in Relapsed/Refractory Large Granular Lymphocyte Leukemia

NCT07692529

Conditions: Evaluation of the Efficacy and Safety of Zeprumetostat in Relapsed/Refractory Large Granular Lymphocyte Leukemia (T-LGLL), Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Nemtabrutinib With Venetoclax and Obinutuzumab in Patients With Chronic Lymphocytic Leukemia

NCT07690891

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Not Yet Recruiting

Reassessment of the Risk of Hemolytic Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With a Regimen Containing Venetoclax

NCT07691047

Conditions: Chronic Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Clinique de l'Europe Amiens, France

Hôpital Privé du Confluent Nantes, France

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions